High PD-L1 expression as a negative prognostic factor in stage III but not in stage II gastric cancer

doi:10.3748/wjg.v32.i8.115333

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 32, Issue 8

This Article

(40)

(77)

(0)

(14)

(869)

(2)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Gastroenterol. Feb 28, 2026; 32(8): 115333
Published online Feb 28, 2026. doi: 10.3748/wjg.v32.i8.115333

Full Size Figure Download Figure

Figure 3 Survival outcomes according to programmed death ligand-1 expression in patients with pathological stage II gastric or gastroesophageal junction cancer. A and B: Kaplan-Meier curves showing disease-free survival (DFS) and overall survival (OS) between programmed death ligand-1 (PD-L1)-positive and PD-L1-negative groups; C and D: Kaplan-Meier curves showing DFS and OS between high and low PD-L1 expression groups. No significant differences in DFS or OS were observed between the groups. PD-L1: Programmed death ligand-1.

Citation: Zhang HM, Li FP, Zhang HY, Liu XR, Chen XH, Liang HY, Yan X, Xie Q, Zhong R, Lai M, Zhong XF, Liu H, Zhao LY. High PD-L1 expression as a negative prognostic factor in stage III but not in stage II gastric cancer. World J Gastroenterol 2026; 32(8): 115333
URL: https://www.wjgnet.com/1007-9327/full/v32/i8/115333.htm
DOI: https://dx.doi.org/10.3748/wjg.v32.i8.115333

Zhang HM, Li FP, Zhang HY, Liu XR, Chen XH, Liang HY, Yan X, Xie Q, Zhong R, Lai M, Zhong XF, Liu H, Zhao LY. High PD-L1 expression as a negative prognostic factor in stage III but not in stage II gastric cancer. World J Gastroenterol 2026; 32(8): 115333 [PMID: 41809879 DOI: 10.3748/wjg.v32.i8.115333]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.